Cue Biopharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Cue Biopharma using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-14 | $-0.20 | $-0.29 | 31.0 % |
Mar 2024 | 2024-05-09 | $-0.25 | $-0.28 | 10.7 % |
Mar 2024 | 2024-04-08 | $-0.28 | $-0.28 | 0.00 % |
Sep 2023 | 2023-11-03 | $-0.24 | $-0.34 | 29.4 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-14 | $2.66M | $1.29M | 106.0 % |
Mar 2024 | 2024-05-09 | $1.72M | $1.21M | 41.9 % |
Mar 2024 | 2024-04-08 | $1.82M | $1.71M | 6.49 % |
Sep 2023 | 2023-11-03 | $2.10M | $1.13M | 85.8 % |
Cue Biopharma (CUE) is scheduled to report earnings on November 1, 2024. The last reported earnings were for reported on August 14, 2024 for Q2.
The Actual EPS was $-0.20, which beat the estimate of $-0.29.
The Actual Revenue was $2.7M, which beat the estimate of $1.3M.
Browse earnings estimates, EPS, and revenue on all stocks.